Journal article

Mesenchymal stem cells attenuate inflammatory processes in the heart and lung via inhibition of TNF signaling


Authors listMartire, Alessandra; Bedada, Fikru B.; Uchida, Shizuka; Poeling, Jochen; Krueger, Marcus; Warnecke, Henning; Richter, Manfred; Kubin, Thomas; Herold, Susanne; Braun, Thomas

Publication year2016

JournalBasic Research in Cardiology

Volume number111

Issue number5

ISSN0300-8428

eISSN1435-1803

Open access statusHybrid

DOI Linkhttps://doi.org/10.1007/s00395-016-0573-2

PublisherSpringer


Abstract
Mesenchymal stem cells ( MSC) have been used to treat different clinical conditions although the mechanisms by which pathogenetic processes are affected are still poorly understood. We have previously analyzed the homing of bone marrow-derived MSC to diseased tissues characterized by a high degree of mononuclear cell infiltration and postulated that MSC might modulate inflammatory responses. Here, we demonstrate that MSC mitigate adverse tissue remodeling, improve organ function, and extend lifespan in a mouse model of inflammatory dilative cardiomyopathy ( DCM). Furthermore, MSC attenuate Lipopolysaccharide-induced acute lung injury indicating a general role in the suppression of inflammatory processes. We found that MSC released sTNF-RI, which suppressed activation of the NFjBp65 pathway in cardiomyocytes during DCM in vivo. Substitution of MSC by recombinant soluble TNF-R partially recapitulated the beneficial effects of MSC while knockdown of TNF-R prevented MSC-mediated suppression of the NFjBp65 pathway and improvement of tissue pathology. We conclude that sTNF-RI is a major part of the paracrine machinery by which MSC effect local inflammatory reactions.



Citation Styles

Harvard Citation styleMartire, A., Bedada, F., Uchida, S., Poeling, J., Krueger, M., Warnecke, H., et al. (2016) Mesenchymal stem cells attenuate inflammatory processes in the heart and lung via inhibition of TNF signaling, Basic Research in Cardiology, 111(5), Article 54. https://doi.org/10.1007/s00395-016-0573-2

APA Citation styleMartire, A., Bedada, F., Uchida, S., Poeling, J., Krueger, M., Warnecke, H., Richter, M., Kubin, T., Herold, S., & Braun, T. (2016). Mesenchymal stem cells attenuate inflammatory processes in the heart and lung via inhibition of TNF signaling. Basic Research in Cardiology. 111(5), Article 54. https://doi.org/10.1007/s00395-016-0573-2



Keywords


acute lung injuryBONE-MARROWENBRELETANERCEPTFIBROSISMesenchymal stem cellsSTROMAL CELLS

Last updated on 2025-10-06 at 10:39